# Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography

> **NCT01230723** · PHASE4 · UNKNOWN · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 30 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DEVICE:** Everolimus-Eluting-Stent
- **DEVICE:** Zotarolimus-Eluting-Stent

## Key facts

- **NCT ID:** NCT01230723
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2011-12
- **Final completion:** 2012-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01230723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01230723, "Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01230723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*